16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
61
Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand.

Aventis Pharma Deutschland
6
Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.

Aventis Pharma Deutschland
1
QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.

Aventis Pharma Deutschland
4
Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.

Aventis Pharma Deutschland
28
Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition.

Aventis Pharma Deutschland
29
Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel.

Aventis Pharma Deutschland
22
Design, synthesis, and structure-activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitors.

Aventis Pharma Deutschland
29
Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.

Aventis Pharma Deutschland
85
Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes.

Aventis Pharma Deutschland
17
Synthesis and activity of novel and selective I(Ks)-channel blockers.

Aventis Pharma Deutschland
32
alpha(v)beta(3) Antagonists based on a central thiophene scaffold.

Aventis Pharma Deutschland
13
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

Karus Therapeutics
217
Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compounds

Dart Neuroscience (Cayman)
72
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

The University of Texas System
26
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

Incyte
54
Tricyclic spiro compound

Ono Pharmaceutical